Patents Assigned to Qu Biologies Inc.
  • Patent number: 10946083
    Abstract: The invention provides methods of modulating an immune system in a vertebrate host for the therapeutic or prophylactic treatment of infection by a first microbial pathogen in a target tissue, comprising administration at an administration site of an effective amount of an antigenic formulation comprising antigenic determinants specific for a second heterologous microbial pathogen.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: March 16, 2021
    Assignee: Qu Biologies Inc.
    Inventors: Harold David Gunn, Salim Dhanji, David W. Mullins